279255-86-6

Upstream product

• 279255-85-5 (R)-O-benzyl 2-N-(t-butoxycarbonyl)amino-3-methylbutanoate 
• 22838-58-0 Boc-D-Val-OH 
• 100-39-0 benzyl bromide 
• 76-05-1 trifluoroacetic acid 

Downstream Products

• 1309055-95-5 D-leucyl-D-valine benzyl ester TFA salt 
• 313693-18-4 C₂₃H₃₆N₂O₅ 

Relevant academic research and scientific papers

N-linked peptidoresorc[4]arene-based receptors as noncompetitive inhibitors for α-chymotrypsin

This paper deals with the design, synthesis, and evaluation of a new series of receptors for protein surface recognition. The design of these agents is based around the attachment of four constrained dipeptide chains onto a central resorc[4]arene scaffold. By varying the sequence, nature, and stereochemistry of the chains we prepared anionically functionalized N-linked peptidoresorc[4] arenes 12, 13, and 17 by Pd/C-catalyzed hydrogenation of the corresponding benzyl esters 10, 11, and 16. From this family of receptors we have identified noncompetitive inhibitors of α-chymotrypsin (ChT), which function by binding to the surface of the enzyme in the neighborhood of the active site cleft (Ki values ranging from 12.4 ± 5.1 μM for free carboxylic acid (+)-12b to 0.76 ± 0.14 μM for benzyl ester (-)-16a). For anionically functionalized receptors 12, 13, and 17 the ChT inhibition is based essentially on electrostatic interaction, and the bound enzyme can be released from the resorcarene surface by increasing the ionic strength, with its activity almost completely restored. For receptors with terminal benzyl ester groups (10 and 16) a hydrophobic network can be suggested.

Sulfonamide hydroxamates

A compound of the Formula (I): wherein Z, R1, R, and Ar2are as defined in the specification. This invention also relates to sulfonamide compounds of the Formula (I) that are inhibitors of procollagen C-proteinase, pharmaceutical compositions containing them, methods for their use, and methods for preparing the compounds.